This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback
Trial record 3 of 592 for:    excel

Chlorhexidine Drying Time (Chlorhexidine)

This study has been completed.
Information provided by (Responsible Party):
University of British Columbia Identifier:
First received: March 19, 2014
Last updated: September 26, 2014
Last verified: September 2014

Before a patient gets a spinal/epidural, their lower back is cleaned with an antiseptic solution diluted in alcohol called ChloraPrep. ChloraPrep must completely dry before starting the anesthetic procedure. It is not known how much time is needed for the solution to completely dry. The investigators aim to determine this.

As the ChloraPrep dries, the alcohol is converted into vapour. The investigators will be using a PPBRae 3000 device to detect small amounts of vapours in the air. As the ChloraPrep dries it gives off less and less vapour. The investigators will use this diminishing vapour concentration to determine when drying is complete.

Condition Intervention
Drying Time Drug: Chlorhexidine gluconate

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: The Minimum ChloraPrep Drying Time Before Neuraxial Anesthesia in Elective Cesarean Delivery Patients - Prospective Observational Study

Resource links provided by NLM:

Further study details as provided by University of British Columbia:

Primary Outcome Measures:
  • Length of drying time [ Time Frame: At Chloraprep application ]
    Length of drying time from when Chloraprep solution is applied to skin to when skin is deemed dry.

Enrollment: 20
Study Start Date: April 2014
Study Completion Date: June 2014
Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Groups/Cohorts Assigned Interventions
Study group
All study participants
Drug: Chlorhexidine gluconate
Other Name: Chloraprep


Ages Eligible for Study:   19 Years to 40 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Elective cesarean patients at BC Women's Hospital

Inclusion Criteria:

  • Pregnant
  • At full term
  • Due to have a cesarean section under spinal or epidural anesthesia
  • 19 to 40 years of age

Exclusion Criteria:

  • Allergy to certain antiseptic solutions
  • Not suitable for a spinal/epidural anesthetic
  • Have a significant amount of hair on lower back
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT02095535

Canada, British Columbia
BC Women's Hospital
Vancouver, British Columbia, Canada, V6H 3N1
Sponsors and Collaborators
University of British Columbia
Principal Investigator: Vit Gunka, MD FRCPC University of British Columbia
  More Information

Responsible Party: University of British Columbia Identifier: NCT02095535     History of Changes
Other Study ID Numbers: H14-00623
Study First Received: March 19, 2014
Last Updated: September 26, 2014

Keywords provided by University of British Columbia:
obstetric patients
drying time

Additional relevant MeSH terms:
Chlorhexidine gluconate
Anti-Infective Agents, Local
Anti-Infective Agents
Dermatologic Agents processed this record on July 19, 2017